Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 7/11/2024
NEW DRUG: Ondexxya for rapid reversal of anticoagulation
Get the info you need on this new product, part of our drug news roundup for July. - 7/10/2024
NEW DRUG: Doptelet for severe and chronic thrombocytopenia
Get the info you need on this new product, part of our drug news roundup for July. - 7/10/2024
NEW DRUG: Velsipity for ulcerative colitis
Get the info you need on this new product, part of our drug news roundup for July. - 7/10/2024
Methylphenidate ER chewable tablets now available for ADHD treatment
Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12. - 7/9/2024
NEW DRUG: Truqap for breast cancer
Get the info you need on this new product, part of our drug news roundup for July. - 7/9/2024
NEW DRUG: Myalepta for leptin deficiency
Get the info you need on this new product, part of our drug news roundup for July. - 7/8/2024
Treatment recommendations for the management of axial spondyloarthritis
Canadian Rheumatology Association’s “living” treatment recommendations provide contemporary guidance on the management of patients with axial spondyloarthritis. - 7/7/2024
Which first-line antidepressants cause the most weight gain?
U.S. study compares weight gain over the first six months of treatment after starting eight different first-line antidepressants. - 7/1/2024
Tirzepatide may help patients with obstructive sleep apnea and obesity
Two double-blind, randomized controlled trials show positive effects of tirzepatide, with or without concomitant use of positive airway pressure therapy. - 6/26/2024
Migraine prevention should include CGRP-targeting therapies as first-line agents
Prior failure of other migraine preventive treatments should not be required before using CGRP-targeting therapies for migraine prevention.
